Owners, management and financials
CVR: 21599042
Secondary names: Novonesis Bioindustrial China A/S
Previous names: A/S PSE 17 NR. 1110, NOVO NORDISK BIOINDUSTRIAL CHINA A/S
DKK 0
Gross profit
Net result: DKK 119,380,365
NOVOZYMES A/S (100%)
CVR · view owners
Lisbet Kragelund
Board: Mikkel Viltoft (chair) and 2 members
CVR · view management
Active
Founded 1 January 1999
CVR · view overview
0 employees
Annual report 2022 · average
Director registered: Lisbet Kragelund
CVR · 18/09/2024
View the full event history
NOVOZYMES BIOINDUSTRIAL CHINA A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1999. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named NOVO NORDISK BIOINDUSTRIAL CHINA A/S and A/S PSE 17 NR. 1110. The management consists of Lisbet Kragelund. The board consists of Mikkel Viltoft (chair), Lisbet Kragelund and Rainer Chapour Lehmann. The company is owned by NOVOZYMES A/S. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 119,380,365 compared with DKK 394,633,084 the year before. Equity in the 2025 report amounted to DKK 1,018,536,331.
Selskabets formål er drift af og investering i forskning, udvikling, produktion og handel med biologiske løsninger, herunder bioteknologiske produkter og processer samt at drive virksomhed, der efter bestyrelsens nærmere bestemmelse står i forbindelse hermed. Selskabet tilstræber at drive sin virksomhed på bæredygtig og ansvarlig vis, herunder i økonomisk, miljømæssig og social henseende.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 0 | 119.4M | 1B | 1B | - | |
| 202401/01/2024 – 31/12/2024 | -1 | 394.6M | 1.3B | 1.3B | - | |
| 202301/01/2023 – 31/12/2023 | 1 | 261M | 1B | 1B | - | |
| 202201/01/2022 – 31/12/2022 | -1 | 132.7M | 915M | 903.5M | 0 | |
| 202101/01/2021 – 31/12/2021 | -33K | 56.1M | 828.8M | 828.8M | 0 | |
| 202001/01/2020 – 31/12/2020 | -32K | 45.6M | 817.8M | 817.8M | 0 | |
| 201901/01/2019 – 31/12/2019 | -38K | 283.5M | 1.1B | 1.1B | 0 | |
| 201801/01/2018 – 31/12/2018 | -68K | -54K | 768.7M | 768.6M | - | |
| 201701/01/2017 – 31/12/2017 | -73K | -58K | 770.2M | 770.2M | - | |
| 201601/01/2016 – 31/12/2016 | -78K | -61K | 770.3M | 770.2M | - | |
| 201501/01/2015 – 31/12/2015 | -90K | -69K | 770.3M | 770.3M | - |
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of NOVOZYMES BIOINDUSTRIAL CHINA A/S is 21599042.
NOVOZYMES BIOINDUSTRIAL CHINA A/S is owned by NOVOZYMES A/S.
The management of NOVOZYMES BIOINDUSTRIAL CHINA A/S consists of Lisbet Kragelund.
The board of NOVOZYMES BIOINDUSTRIAL CHINA A/S consists of Mikkel Viltoft, Lisbet Kragelund and Rainer Chapour Lehmann, with Mikkel Viltoft as chair.
In 2025, NOVOZYMES BIOINDUSTRIAL CHINA A/S reported a gross profit of DKK 0.
NOVOZYMES BIOINDUSTRIAL CHINA A/S had an average of 0 employees in the 2022 financial year according to the annual report.
Claim this page to add your logo and social links. Free to get started.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2025. Gross profit came to DKK 0, and the net result was DKK 119,380,365.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2024. Gross profit came to DKK -1, and the net result was DKK 394,633,084.
As of September 18, 2024, Lisbet Kragelund has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of September 18, 2024, Randi Camilla Kinch Jensen has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of September 18, 2024, Lisbet Kragelund is registered as director of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of September 18, 2024, Randi Camilla Kinch Jensen has stepped down as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2023. Gross profit came to DKK 1, and the net result was DKK 261,035,112.
As of June 7, 2024, EY Godkendt Revisionspartnerselskab has been appointed auditor of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of June 7, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of November 2, 2023, Rainer Chapour Lehmann has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of November 2, 2023, Lars Green has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2022. Gross profit came to DKK -1, and the net result was DKK 132,670,108.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2021. Gross profit came to DKK -33,035, and the net result was DKK 56,066,583.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2020. Gross profit came to DKK -31,924, and the net result was DKK 45,639,311.
As of January 18, 2021, Lars Green has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of January 18, 2021, Randi Camilla Kinch Jensen has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of January 18, 2021, Tina Sejersgård Fanø has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of January 18, 2021, Andrew Patrick Fordyce has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2019. Gross profit came to DKK -37,500, and the net result was DKK 283,492,654.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2018. Gross profit came to DKK -67,702, and the net result was DKK -53,650.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2017. Gross profit came to DKK -73,105, and the net result was DKK -57,773.
As of August 10, 2017, Tina Sejersgård Fanø has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of August 10, 2017, Benny Dalgaard Loft has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2016. Gross profit came to DKK -77,546, and the net result was DKK -61,067.
As of September 16, 2016, Randi Camilla Kinch Jensen is registered as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of September 16, 2016, Benny Dalgaard Loft has stepped down as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2015. Gross profit came to DKK -89,648, and the net result was DKK -69,047.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2014.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2013.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2012.
As of May 14, 2013, Andrew Patrick Fordyce has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of May 14, 2013, Peder Holk Nielsen has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of May 14, 2013, Benny Dalgaard Loft is registered as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of May 14, 2013, Peder Holk Nielsen has stepped down as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of May 21, 2010, Mikkel Viltoft has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of May 21, 2010, Peder Holk Nielsen has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of May 21, 2010, Kristian Merser has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of May 21, 2010, Thomas Videbæk has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of May 21, 2010, Peder Holk Nielsen is registered as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of May 21, 2010, Benny Dalgaard Loft has stepped down as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of November 15, 2007, Kristian Merser has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of November 15, 2007, Thomas Videbæk has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of November 15, 2007, Steen Riisgaard has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of December 7, 2006, Benny Dalgaard Loft has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of December 7, 2006, Per Artur Fredrik Månsson has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of December 7, 2006, Benny Dalgaard Loft is registered as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of December 7, 2006, Per Artur Fredrik Månsson has stepped down as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of June 1, 2006, A/S PSE NR. 4820 has been appointed auditor of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of June 1, 2006, Pricewaterhouse Coopers has stepped down as auditor of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of October 30, 2001, A/S PSE NR. 4820 has stepped down as auditor of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of November 14, 2000, Steen Riisgaard has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of November 14, 2000, Per Artur Fredrik Månsson has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of November 14, 2000, Kurt Anker Nielsen has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of November 14, 2000, Mads Øvlisen has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of November 14, 2000, Ole Falvig Ramsby has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of November 14, 2000, Per Artur Fredrik Månsson is registered as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of November 14, 2000, Kurt Anker Nielsen has stepped down as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of November 14, 2000, NOVOZYMES A/S is registered as an owner of NOVOZYMES BIOINDUSTRIAL CHINA A/S with an ownership share of 100%.
On September 18, 2000, the company changed its name from NOVO NORDISK BIOINDUSTRIAL CHINA A/S to NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of December 8, 1999, A/S PSE NR. 4820 has been appointed auditor of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of December 8, 1999, JUT NR. 2180 A/S has stepped down as auditor of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of December 8, 1999, Kurt Anker Nielsen has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of December 8, 1999, Mads Øvlisen has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of December 8, 1999, Ole Falvig Ramsby has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of December 8, 1999, Kim Madsen has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of December 8, 1999, Peter Andreas Stakemann has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of December 8, 1999, Annemette Heller has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of December 8, 1999, Kurt Anker Nielsen is registered as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of December 8, 1999, Peter Andreas Stakemann has stepped down as director of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
On December 8, 1999, the company changed its name from A/S PSE 17 NR. 1110 to NOVO NORDISK BIOINDUSTRIAL CHINA A/S.
As of January 1, 1999, JUT NR. 2180 A/S has been appointed auditor of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of January 1, 1999, Pricewaterhouse Coopers has been appointed auditor of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of January 1, 1999, Kim Madsen has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of January 1, 1999, Peter Andreas Stakemann has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of January 1, 1999, Annemette Heller has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of January 1, 1999, Peter Andreas Stakemann is registered as director of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
NOVOZYMES BIOINDUSTRIAL CHINA A/S was founded on January 1, 1999.
Companies in the same industry and area
CVR 40121846
CVR 37868957
CVR 33392982
CVR 39866471
CVR 45897125
